Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
facilities, and opportunities for professional development. The University provides support for internationally recruited employees with their transition to work and live in Finland. For more on the University
-
& al. 2022, PMID: 35164752,Gondane & al. 2023, PMID: 36975490, and Liang & al. 2024, PMID: 38775167). For further information, please refer to our research groups’ web pages: https://www.helsinki.fi/en
-
at the Faculty of Medicine, University of Helsinki. The project will focus on using and extending deep learning-based approaches developed within the group to integrate bulk multi-omics cancer data. The Kuijjer
-
Cancer Medicine at the Faculty of Medicine, University of Helsinki. The project will focus on developing approaches for gene regulatory network modeling on deconvoluted bulk data, with applications to pan
-
will work within the research project “Structural correctness in metagenomics assembly” funded by the Research Council of Finland in the research group of University Lecturer Leena Salmela. We develop
-
. We will develop an isotope version of a process-based CH4 model and update the representation of different wetland types in the model using a data inversion approach. Additionally, we will analyze
-
metagenomics assembly” funded by the Research Council of Finland in the research group of University Lecturer Leena Salmela. We develop models, algorithms and data structures for high throughput sequencing data
-
medication security are challenged by the high costs of development, manufacture and distribution, evaluation of preclinical safety and efficacy, and the dependence of drug manufacturing on international
-
Sini Laakso’s lab Autoimmune Neurology at the Translational Immunology Research Program at University of Helsinki, Faculty of Medicine invites applications for the position of POSTDOCTORAL
-
the candidate can start in autumn 2025. Background Our group develops and applies systems pharmacology strategies to design rational combinatorial therapies for cancer. We combine both computational (dry-lab) and